SCHEMBL48207

SCHEMBL48207

CCc1ccc(Cc2cc(Cl)ccc2O)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
CYP3A4 P08684 4/20 0.69
HIF1A Q16665 3/20 0.69
HPGD P15428 2/20 0.69
ALOX15 P16050 2/20 0.69
HSD17B10 Q99714 2/20 0.69
MAPT P10636 4/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
LMNA P02545 2/20 0.66
USP2 O75604 2/20 0.66
CASP1 P29466 2/20 0.66
SLC22A1 O15245 1/20 0.66
HSP90AA1 P07900 1/20 0.66
HSPD1 P10809 1/20 0.66
HSPA5 P11021 1/20 0.66
IDO1 P14902 1/20 0.66
ALOX12 P18054 1/20 0.66
HTT P42858 1/20 0.66
BLM P54132 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27626950 0.89 HIF1A (0.79) MEN1KMT2ACYP3A4HIF1AHPGD
SCHEMBL27946745 0.85 MEN1 (0.73) MEN1KMT2ACYP3A4HIF1AHPGD
Clorophene SCHEMBL9810889 0.83 HIF1A (0.87) MEN1KMT2ACYP3A4HIF1AHPGD
Clorophene SCHEMBL78119 0.81 HIF1A (1.00) MEN1KMT2ACYP3A4HIF1AHPGD
Clorophene SCHEMBL29377427 0.81 HIF1A (1.00) MEN1KMT2ACYP3A4HIF1AHPGD
Dichlorophen SCHEMBL2453304 0.81 CYP3A4 (0.83) MEN1KMT2ACYP3A4HIF1AHPGD
SCHEMBL364080 0.81 HIF1A (0.68) MEN1KMT2ACYP3A4HIF1AHPGD
Dichlorophen SCHEMBL29349447 0.80 CYP3A4 (1.00) MEN1KMT2ACYP3A4HIF1AHPGD
Dichlorophen SCHEMBL9109126 0.80 CYP3A4 (1.00) MEN1KMT2ACYP3A4HIF1AHPGD
Dichlorophen SCHEMBL29524636 0.80 CYP3A4 (1.00) MEN1KMT2ACYP3A4HIF1AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2230907-B1 BENZYLPHENYL CYCLOHEXANE DERIVATIVES AND METHODS OF USE THERACOS INC (US) 2018-05-09 EP disclosed
US-8129434-B2 Benzylphenyl cyclohexane derivatives and methods of use THERACOS, INC. (US) 2012-03-06 US disclosed
US-8129434-B2 Benzylphenyl cyclohexane derivatives and methods of use THERACOS, INC. (US) 2012-03-06 US disclosed
US-8129434-B2 Benzylphenyl cyclohexane derivatives and methods of use THERACOS, INC. (US) 2012-03-06 US disclosed
CN-101938902-A Benzylphenylcyclohexane derivatives and methods of use THERACOS INC 2011-01-05 CN disclosed
EP-2230907-A1 BENZYLPHENYL CYCLOHEXANE DERIVATIVES AND METHODS OF USE Theracos, Inc. (US) 2010-09-29 EP disclosed
US-20090156516-A1 BENZYLPHENYL CYCLOHEXANE DERIVATIVES AND METHODS OF USE SEED, BRIAN 2009-06-18 US disclosed
US-20090156516-A1 BENZYLPHENYL CYCLOHEXANE DERIVATIVES AND METHODS OF USE SEED, BRIAN 2009-06-18 US disclosed
WO-2009076550-A1 BENZYLPHENYL CYCLOHEXANE DERIVATIVES AND METHODS OF USE THERACOS, INC. (US) 2009-06-18 WO disclosed
WO-2009076550-A1 BENZYLPHENYL CYCLOHEXANE DERIVATIVES AND METHODS OF USE THERACOS, INC. (US) 2009-06-18 WO disclosed
US-7414072-B2 Aryl 5-thio-β-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-08-19 US disclosed
CN-100341885-C Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides TAISHO PHARMACEUTICAL CO LTD (JP) 2007-10-10 CN disclosed
US-7250522-B2 Method for selective preparation of aryl 5-thio-β-D-aldohexopyranosides TAISHO PHARMACEUTICAL CO., LTD. (JP) 2007-07-31 US disclosed
CN-1312165-C Aryl 5-thio-beta-D-glucopyranoside derivative and therapeutic agent for diabetes containing the same TAISHO PHARMACEUTICAL CO LTD (JP) 2007-04-25 CN disclosed
US-20050256317-A1 Process for selective production of aryl 5-thio-beta-d- aldohexopyranosides TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
CN-1675233-A Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides TAISHO PHARMACEUTICAL CO LTD (JP) 2005-09-28 CN disclosed
US-20050209309-A1 Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same TAISHO PHARMACEUTICAL CO., LTD. 2005-09-22 US disclosed
CN-1639180-A Aryl 5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same TAISHO PHARMACEUTICAL CO LTD (JP) 2005-07-13 CN disclosed
EP-1541578-A1 PROCESS FOR SELECTIVE PRODUCTION OF ARYL 5-THIO-BETA-D-ALDOHEXOPYRANOSIDES TAISHO PHARMACEUTICAL CO., LTD (JP) 2005-06-15 EP disclosed
EP-1528066-A1 ARYL 5-THIO-D-GLUCOPYRANOSIDE DERIVATIVES AND REMEDIES FOR DIABETES CONTAINING THE SAME TAISHO PHARMACEUTICAL CO., LTD (JP) 2005-05-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156516-A1 BENZYLPHENYL CYCLOHEXANE DERIVATIVES AND METHODS OF USE SLC5A2, SLC5A1, SLC2A8 MEN1 3770/4885KMT2A 2114/4885CYP3A4 366/4885
US-20050256317-A1 Process for selective production of aryl 5-thio-beta-d- aldohexopyranosides ALDOA, DERA, AKR1D1 MEN1 3994/4885KMT2A 3446/4885CYP3A4 332/4885
US-20050209309-A1 Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same SLC5A2, SLC5A1, UGGT1 MEN1 4835/4885KMT2A 1778/4885CYP3A4 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.